Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer
Simone Bertz(Friedrich-Alexander-Universität Erlangen-Nürnberg), Arndt Hartmann(Universitätsklinikum Erlangen), Wolf F. Wieland(University of Regensburg), Stefan Denzinger(University of Regensburg), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ferdinand Hofstädter(University of Regensburg), Stefan Link(University of Regensburg), Maximilian Burger(University of Regensburg), Wolfgang Otto(University of Regensburg)
Cited by 104
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258